Minocycline offers no benefit in treating dry age-related macular degeneration
age-related macular degeneration

Minocycline offers no benefit in treating dry age-related macular degeneration

Minocycline, a commonly prescribed antibiotic that also offers anti-inflammatory effects, does not offer any benefits to those suffering from dry age-related macular degeneration.
Phase 2 trial complete for minocycline therapy for dry eye
dry eye

Phase 2 trial complete for minocycline therapy for dry eye

Minocycline has long been recognized by ophthalmologists for its anti-inflammatory properties and a new eyedrop therapy is being developed for dry eye sufferers.